Evidence map›Paper›PMID 38553439›Full record

ArticleNature communications2024

Colonisation of hospital surfaces from low- and middle-income countries by extended spectrum β-lactamase- and carbapenemase-producing bacteria.

Maria Nieto-Rosado, Kirsty Sands, Edward A R Portal, Kathryn M Thomson, Maria J Carvalho, Jordan Mathias, Rebecca Milton, Calie Dyer, Chinenye Akpulu, Ian Boostrom and 35 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Genetic features of blaBMC microbiology · 2025
    Article
  9. Widespread Distribution of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Co-Motif-Engineered RuOACS applied materials & interfaces · 2025
    Article
  14. Lyophilized and Oven-DriedPlants (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Draft genome sequence data ofData in brief · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 16 institutions in 8 countries.

Maria Nieto-Rosado *Department of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK. maria.nietorosado@biology.ox.ac.uk.ORCID http://orcid.org/0000-0001-6188-5947
Kirsty Sands *Department of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5049-4481
Edward A R PortalDepartment of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-2142-3443
Kathryn M ThomsonDepartment of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.
Maria J CarvalhoDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Jordan MathiasDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Rebecca MiltonDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Calie DyerDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Chinenye AkpuluDepartment of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.
Ian BoostromDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Patrick HoganDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Habiba SaifDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Ana D Sanches FerreiraDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Thomas HenderDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Barbra PortalDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Robert AndrewsDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
W John WatkinsDivision of Infection and Immunity, Cardiff University, Cardiff, UK.
Rabaab ZahraDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
Haider ShiraziPakistan Institute of Medical Sciences, Islamabad, Pakistan.
Adil MuhammadDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.ORCID http://orcid.org/0000-0002-0083-4668
Syed Najeeb UllahDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
Muhammad Hilal JanDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
Shermeen AkifDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
Kenneth C IregbuNational Hospital Abuja, Abuja, Nigeria.ORCID http://orcid.org/0000-0003-4780-0497
Fatima ModibboDébbo Africa, Lekki, Lagos, Nigeria.
Stella UwaezuokeFederal Medical Centre Jabi, Abuja, Nigeria.
Lamidi AuduNational Hospital Abuja, Abuja, Nigeria.ORCID http://orcid.org/0000-0002-9836-2717
Chinago P EdwinDepartment of Microbiology, Medway Maritime Hospital NHS Foundation Trust, Gillingham, Kent, UK.
Ashiru H YusufAminu Kano Teaching Hospital, Kano, Nigeria.
Adeola AdeleyeMurtala Muhammad Specialist Hospital, Kano City, Nigeria.
Aisha S MukkadasMurtala Muhammad Specialist Hospital, Kano City, Nigeria.
Jean Baptiste MazaratiThe National Reference Laboratory, Rwanda Biomedical Centre, Kigali, Rwanda.
Aniceth RucogozaThe National Reference Laboratory, Rwanda Biomedical Centre, Kigali, Rwanda.
Lucie GajuThe National Reference Laboratory, Rwanda Biomedical Centre, Kigali, Rwanda.
Shaheen MehtarUnit of IPC, Stellenbosch University, Cape Town, South Africa.
Andrew N H BulabulaInfection Control Africa Network, Cape Town, South Africa.
Andrew WhitelawDivision of Medical Microbiology, Stellenbosch University, Cape Town, South Africa.ORCID http://orcid.org/0000-0001-9070-5247
Lauren RobertsDivision of Medical Microbiology, Stellenbosch University, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-2637-6319
Grace ChanDepartment of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Delayehu BekeleDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
Semaria SolomonDepartment of Microbiology, Immunology and Parasitology, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Mahlet AbaynehDepartment of Pediatrics and Child Health, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Gesit MetaferiaDepartment of Microbiology, Immunology and Parasitology, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Group BARNARDS
Timothy R WalshDepartment of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.
Cardiff University · GBUniversity of Oxford · GBQuaid-i-Azam University · PKRwanda Biomedical Center · RWStellenbosch University · ZASt. Paul's Hospital Millennium Medical College · ETNational Hospital Abuja · NGAminu Kano Teaching Hospital · NGBoston Children's Hospital · USFederal Medical Centre · NGHarvard University · USMedway Maritime Hospital · GBNational Health Laboratory Service · ZAPakistan Institute of Medical Sciences · PKUniversity of Aveiro · PTWellcome Sanger Institute · GB

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) OP1191522Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) OPP1119772
6 · The paper itself

Abstract

Hospital surfaces can harbour bacterial pathogens, which may disseminate and cause nosocomial infections, contributing towards mortality in low- and middle-income countries (LMICs). During the BARNARDS study, hospital surfaces from neonatal wards were sampled to assess the degree of environmental surface and patient care equipment colonisation by Gram-negative bacteria (GNB) carrying antibiotic resistance genes (ARGs). Here, we perform PCR screening for extended-spectrum β-lactamases (bla

Indexed as

Developing CountriesNeonatal SepsisAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesGram-Negative BacteriaHospitalsHumansInfant, NewbornKlebsiella pneumoniaeMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemase

Identifiers

PMID38553439
PMCPMC10980694
OpenAlexW4393319404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.